SmartCells
SmartCells develops insulin and polymer-based products for the treatment of diabetes, fertility, thyroid, and growth hormone deficiencies.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed SmartCells Information
SmartCells was acquired by
Merck Sharp &a; Dohme Sweden AB.
The acquisition happend on 2010-12-02.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: Beverly
State: Massachusetts
Zip:
Country: United States
Financial Info
Stage:
series d
Raised Last:
$4M
Raised Total:$13M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company&s;s polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
